TerminatedPhase 2

A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of Venglustat (GZ/SAR402671) in Parkinson's Disease Patients Carrying a Glucocerebrosidase (GBA) Gene Mutation

NCT02906020

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Investigational Site Number :8400017

Scottsdale, Arizona, United States

+51 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2016-12-15
Enrollment: 273 participants
Sponsor: Genzyme, a Sanofi Company
Purpose: treatment

Locations (52)

Investigational Site Number :8400017Scottsdale, Arizona, United States
Investigational Site Number :8400011Scottsdale, Arizona, United States
Investigational Site Number :8400004La Jolla, California, United States
Investigational Site Number :8400019Palo Alto, California, United States
Investigational Site Number :8400013Sunnyvale, California, United States
Investigational Site Number :8400015New Haven, Connecticut, United States
Investigational Site Number :8400008Boca Raton, Florida, United States
Investigational Site Number :8400016Chicago, Illinois, United States
Investigational Site Number :8400005Chicago, Illinois, United States
Investigational Site Number :8400014Boston, Massachusetts, United States
Investigational Site Number :8400018New York, New York, United States
Investigational Site Number :8400010New York, New York, United States
Investigational Site Number :8400001New York, New York, United States
Investigational Site Number :8400021Portland, Oregon, United States
Investigational Site Number :8400020Portland, Oregon, United States
Investigational Site Number :8400009Portland, Oregon, United States
Investigational Site Number :8400002Philadelphia, Pennsylvania, United States
Investigational Site Number :8400006Fairfax, Virginia, United States
Investigational Site Number :8400012Kirkland, Washington, United States
Investigational Site Number :0400001Innsbruck, Austria
Investigational Site Number :1240003Vancouver, British Columbia, Canada
Investigational Site Number :1240002Ottawa, Ontario, Canada
Investigational Site Number :1240001Montreal, Quebec, Canada
Investigational Site Number :2500001Paris, France
Investigational Site Number :2760002Kiel, Germany
Investigational Site Number :2760001Tübingen, Germany
Investigational Site Number :3000002Larissa, Greece
Investigational Site Number :3760002Haifa, Israel
Investigational Site Number :3760003Petah Tikva, Israel
Investigational Site Number :3760001Tel Aviv, Israel
Investigational Site Number :3760004Tel Litwinsky, Israel
Investigational Site Number :3800006Rozzano, Milano, Italy
Investigational Site Number :3800001Catanzaro, Italy
Investigational Site Number :3800004Milan, Italy
Investigational Site Number :3800003Pavia, Italy
Investigational Site Number :3800002Salerno, Italy
Investigational Site Number :3920005Nagoya, Aichi-ken, Japan
Investigational Site Number :3920002Kyoto, Kyoto, Japan
Investigational Site Number :3920004Osaka, Osaka, Japan
Investigational Site Number :3920001Bunkyo-ku, Tokyo, Japan
Investigational Site Number :3920003Kodaira-shi, Tokyo, Japan
Investigational Site Number :5780001Trondheim, Norway
Investigational Site Number :6200002Coimbra, Portugal
Investigational Site Number :6200003Torres Vedras, Portugal
Investigational Site Number :7020001Singapore, Singapore
Investigational Site Number :7020002Singapore, Singapore
Investigational Site Number :7240002Barcelona, Barcelona [Barcelona], Spain
Investigational Site Number :7240001Seville, Spain
Investigational Site Number :7520001Stockholm, Sweden
Investigational Site Number :1580001Taoyuan County, Taiwan
Investigational Site Number :8260001London, London, City of, United Kingdom
Investigational Site Number :8260002Oxford, Oxfordshire, United Kingdom